Dawn Hershman, M.D., M.S. is assistant professor of medicine at the Columbia University College of Physicians and Surgeons in the division of medical oncology and has completed a masters of science in biostatistics with an emphasis on patient-oriented research at the Mailman School of Public Health.
She received her M.D. from The Albert Einstein College of Medicine and then trained in internal medicine at Columbia Presbyterian Medical Center, where she served as chief resident. She then completed a fellowship in medical oncology/hematology. She is now the director of the Clinical Breast Oncology Program. She has an interest and expertise in the area of health outcomes research with a specific interest in supportive care, racial disparities, and breast cancer survivorship.
Dr. Hershman has worked on several studies using decision analysis models to determine the effectiveness of chemoprevention for groups of women at high risk of developing breast cancer. She has an interest and expertise in the area of health outcomes research with a specific interest in supportive care, racial disparities in quality of care, and breast cancer survivorship.
Dr. Hershman is PI-investigator on grants from the American Cancer Society, the Department of Defense, the American Society of Clinical Oncologists, and the Komen Foundation. She is actively involved in survivorship research through the Southwest Oncology group and therapeutic trials through the M.D. Anderson Prevention Consortium and the New York Cancer Consortium, and has several clinical trials aimed at reducing side effects of cancer therapy. She has developed a clinical research program at Columbia University Medical Center to understand and prevent short- and long-term complications in cancer survivors.